Mechanisms and Prevention of Sudden Death in Multiple System Atrophy
Overview
Authors
Affiliations
Background: Sudden death in multiple system atrophy (MSA) usually occurs during sleep and was therefore attributed to suffocation resulting from vocal cord abductor paralysis, a characteristic laryngeal finding of MSA. This led to the use of tracheostomy and noninvasive positive pressure ventilation (NPPV) for the prevention of sudden death. However, neither method has been able to prevent sudden death, and both have occasionally precipitated treatment-related complications, including central sleep apneas and exacerbation of floppy epiglottis. Therefore, it is important to determine the mechanisms and prevention of sudden death in MSA.
Methods: We reviewed the literature on the mechanisms and prevention of sudden death in patients with MSA.
Results: Sudden death in MSA is hypothesized to be a consequence of disordered central respiration, suffocation caused by sputum and food, upper airway obstruction from NPPV acting on a floppy epiglottis, cardiac autonomic disturbance, or a combination of these factors.
Conclusion: Various factors may be involved in the mechanism of sudden death in MSA. A multidisciplinary approach is needed to prevent sudden death, and this requires an organized system of several medical specialties. Neurologists require a cooperative network that includes experts in otorhinolaryngology, sleep medicine, dysphagia rehabilitation, and cardiology.
Esophageal Dysmotility in Multiple System Atrophy: A Retrospective Cross-Sectional Study.
Ueha R, Koyama M, Seto A, Sato T, Goto T, Orimo K J Clin Med. 2024; 13(17).
PMID: 39274241 PMC: 11396424. DOI: 10.3390/jcm13175026.
Yoshitake M, Sugiyama A, Shimohata T, Araki N, Suzuki M, Shibuya K BMC Neurol. 2024; 24(1):160.
PMID: 38741055 PMC: 11089725. DOI: 10.1186/s12883-024-03666-4.
Wang J, Sugiyama A, Yokota H, Hirano S, Yamamoto T, Yamanaka Y Diagnostics (Basel). 2024; 14(2).
PMID: 38248077 PMC: 10814850. DOI: 10.3390/diagnostics14020201.
Correlations between serotonin impairments and clinical indices in multiple system atrophy.
Nagao R, Mizutani Y, Shima S, Ueda A, Ito M, Yoshimoto J Eur J Neurol. 2023; 31(3):e16158.
PMID: 38085271 PMC: 11235942. DOI: 10.1111/ene.16158.
Asakawa T, Ogino M, Tominaga N, Ozaki N, Kubo J, Kakuda W Prog Rehabil Med. 2023; 8:20230035.
PMID: 37790746 PMC: 10542584. DOI: 10.2490/prm.20230035.